From time to time, CJASN will solicit commentaries from the nephrology community to address controversial topics that have particular importance to the practice of renal medicine. All submissions must be 500 words or fewer and will undergo peer review. CJASN will endeavor to publish representative commentaries, but cannot guarantee that any one submission will appear in print. Instructions for these submissions can be found under the Instructions to Authors tab on the CJASN website (http://www.cjasn.org).
This issue of CJASN includes a series of papers in its Controversies in Nephrology feature that addresses the role of industry in the development of clinical practice guidelines. Owing to the vital role that clinical practice guidelines have assumed in the nephrology community, we believe there will be both widespread interest in these contributions as well as many important opinions and insights among our readership. We therefore welcome comments from individuals and organizations wishing to express their views on this issue. The articles in this Controversies in Nephrology series include an overview, two primary contributions, and rebuttals written by these same authors. Commentaries must be received on or before January 15, 2007, to be considered for the March issue of CJASN.
Commentaries received after January 15, 2007, will be considered for future issues of CJASN.
- Copyright © 2007 by the American Society of Nephrology